Example: Heart Attack

Search clinical trials for: Glimepiride

Total 252 results

NCT01052909

Completed

Bioequivalence Study of Dr.Reddy's Laboratories Limited, Glimepiride Tablets 1 mg Under Fasting Condition

Conditions: Healthy
NCT03917940

Completed

Omega 3 Fatty Acids on Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride

Conditions: Diabetic Patients
NCT01053689

Completed

Bioequivalence Study of Dr.Reddys Laboratories Limited, Glimepiride 1 mg Tablets in Healthy Subjects Under Fed Condition

Conditions: Healthy
NCT04240171

Recruiting

Dapagliflozin Versus Glimepiride Effect in Patient With Type 2 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 2
NCT01496443

Completed

TAK-875 Glimepiride Drug-Interaction Study

Conditions: Pharmacokinetics
NCT02954822

Completed

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg

Conditions: Type2 Diabetes
NCT01453049

Terminated

An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients

Conditions: Diabetes Mellitus, Type 2
NCT01768455

Completed

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male Subjects

Conditions: Healthy
NCT01204580

Completed

ADIponectin and Asymmetric Dimethylarginine (ADMA) Level in Type-2 Diabetes Patients After 12 Weeks of Treatment With GlimepiRide And Metformin Fixed Dose Combination

Conditions: Diabetes Mellitus, Type 2
NCT02280486

Completed

Efficacy and Safety of Saxagliptin VS. Glimepiride in Chinese T2DM Patients Controlled Inadequately With Metformin

Conditions: Type 2 Diabetes
NCT01509001

Completed

Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes
NCT02426294

Unknown status

Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin

Conditions: Type 2 Diabetes Mellitus
NCT01677247

Completed

Bioequivalence Study of 4 mg Glimepiride Tablet

Conditions: Glimepiride BE Study in Healthy Volunteers Under Fasting Condition
NCT01863667

Terminated

A Study to Evaluate the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)

Conditions: Type 2 Diabetes Mellitus
NCT01459809

Completed

Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients

Conditions: Diabetes Mellitus, Type 2
NCT02026310

Completed

Efficacy/Safety Study of Glimepiride to Type 2 Diabetes Patients Based on Metformin And Basal Insulin Treatment

Conditions: Diabetes Mellitus, Type 2
NCT00776620

Completed

Bioequivalence Study of Glimepiride 1mg Tablets Under Fed Conditions

Conditions: Healthy
NCT00776490

Completed

Bioequivalence Study of Glimepiride 1mg Tablets Under Fasting Conditions

Conditions: Healthy
NCT00908921

Completed

Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM)

Conditions: Diabetes Mellitus, Type 2
NCT02919059

Unknown status

Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.

Conditions: Diabetes Mellitus, Type 2
NCT02089126

Unknown status

Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes

Conditions: Type 2 Diabetes Mellitus
NCT01829477

Terminated

Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes

Conditions: Diabetes Mellitus, Type 2
NCT00834340

Completed

Glimepiride 4 mg Tablets Under Fasting Conditions

Conditions: Healthy
NCT00835172

Completed

Glimepiride 4 mg Tablets Under Non-Fasting Conditions

Conditions: Healthy
NCT02098746

Completed

Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to Pioglitazone

Conditions: Type 2 Diabetes